ATE452909T1 - Für ein homologes des humanen, für mehrfachresistenz verantwortlichen, p- glykoproteins auf chromosom 7p15-21 kodierendes gen sowie verwendungen dafür - Google Patents

Für ein homologes des humanen, für mehrfachresistenz verantwortlichen, p- glykoproteins auf chromosom 7p15-21 kodierendes gen sowie verwendungen dafür

Info

Publication number
ATE452909T1
ATE452909T1 AT01941884T AT01941884T ATE452909T1 AT E452909 T1 ATE452909 T1 AT E452909T1 AT 01941884 T AT01941884 T AT 01941884T AT 01941884 T AT01941884 T AT 01941884T AT E452909 T1 ATE452909 T1 AT E452909T1
Authority
AT
Austria
Prior art keywords
chromosome
homologue
glycoproteins
multidrug resistance
human gene
Prior art date
Application number
AT01941884T
Other languages
English (en)
Inventor
Markus Frank
Mohamed Sayegh
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Application granted granted Critical
Publication of ATE452909T1 publication Critical patent/ATE452909T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT01941884T 2000-06-05 2001-06-05 Für ein homologes des humanen, für mehrfachresistenz verantwortlichen, p- glykoproteins auf chromosom 7p15-21 kodierendes gen sowie verwendungen dafür ATE452909T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20891300P 2000-06-05 2000-06-05
PCT/US2001/018032 WO2001094400A2 (en) 2000-06-05 2001-06-05 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF

Publications (1)

Publication Number Publication Date
ATE452909T1 true ATE452909T1 (de) 2010-01-15

Family

ID=22776565

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01941884T ATE452909T1 (de) 2000-06-05 2001-06-05 Für ein homologes des humanen, für mehrfachresistenz verantwortlichen, p- glykoproteins auf chromosom 7p15-21 kodierendes gen sowie verwendungen dafür

Country Status (11)

Country Link
US (6) US6846883B2 (de)
EP (5) EP1290028B1 (de)
AT (1) ATE452909T1 (de)
CA (1) CA2411101C (de)
CY (2) CY1109941T1 (de)
DE (1) DE60140868D1 (de)
DK (4) DK2298799T3 (de)
ES (4) ES2540102T3 (de)
HK (1) HK1257165A1 (de)
PT (4) PT2230253E (de)
WO (1) WO2001094400A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1290028B1 (de) 2000-06-05 2009-12-23 The Brigham And Women's Hospital, Inc. Für ein homologes des humanen, für mehrfachresistenz verantwortlichen, p-glykoproteins auf chromosom 7p15-21 kodierendes gen sowie verwendungen dafür
WO2003025174A2 (en) * 2001-09-06 2003-03-27 Bayer Healthcare Ag Regulation of human mrp1-like protein
HUE059011T2 (hu) * 2006-05-31 2022-09-28 Childrens Medical Center Immunmodulátorként szolgáló ABC5-pozitív mezenchimális õssejtek
DK2155248T3 (en) 2007-04-12 2015-09-14 Brigham & Womens Hospital Targeting abcb5 for cancer therapy
PT3130923T (pt) 2008-11-14 2020-06-17 Brigham & Womens Hospital Inc Métodos terapêuticos relacionados com células estaminais
US11542328B2 (en) 2008-11-14 2023-01-03 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
AU2014219026B2 (en) 2013-02-19 2018-11-29 Children's Medical Center Corporation ABCB5(+) stem cells for treating ocular disease
EP4008369A1 (de) 2013-05-10 2022-06-08 Children's Medical Center Corporation Wundheilung und gewebeaufbau
CA3030603A1 (en) 2016-07-14 2018-01-18 University Of Southern California Methods and composition for producing and using immune cells and stem cells for cell-based therapies
WO2019210109A1 (en) 2018-04-25 2019-10-31 Children's Medical Center Corporation Abcb5 ligands and substrates
AU2021262864A1 (en) * 2020-04-30 2022-11-17 Children's Medical Center Corporation Antibodies specific to ABCB5 and uses thereof

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0174810B1 (de) * 1984-09-10 1993-07-21 HSC Research Development Corporation Vielfache Drogen-Resistenz in Säugetierzellinien und Isolierung der determinanten Glykoprotein-DNS
US4837306A (en) 1985-02-25 1989-06-06 The Ontario Cancer Institute Method for selecting hybridomas producing antibodies specific to the P-glycoprotein cell suface antigen and a cDNA clone encoding the C-terminal portion of the antigen
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5399483A (en) 1989-03-30 1995-03-21 Suntory Limited Expression of MDR-related gene in yeast cell
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US5434075A (en) * 1992-03-20 1995-07-18 Board Of Trustees Of The University Of Illinois Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
IT1257893B (it) * 1992-06-17 1996-02-16 Ist Superiore Sanita Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteina umana.
WO1994009363A1 (en) * 1992-10-14 1994-04-28 Board Of Regents, The University Of Texas System Cancer diagnosis and therapy
EP0882717B1 (de) 1996-10-01 2010-09-08 Kyowa Hakko Kirin Co., Ltd. Stickstoff enthaltende heterocyclische verbindungen
US6020191A (en) 1997-04-14 2000-02-01 Genzyme Corporation Adenoviral vectors capable of facilitating increased persistence of transgene expression
US6008002A (en) * 1997-09-29 1999-12-28 Bodey; Bela Immunomagnetic detection and isolation of cancer cells
CZ298364B6 (cs) * 1998-02-05 2007-09-05 Smithkline Beecham Biologicals S. A. Deriváty antigenu asociovaných s nádory z MAGE rodiny a sekvence nukleových kyselin kodující tyto deriváty, jejich použití pro prípravu fúzních proteinu a prostredku pro vakcinaci
AU749675B2 (en) 1998-03-13 2002-07-04 Mesoblast International Sarl Uses for human non-autologous mesenchymal stem cells
AU785363B2 (en) * 1999-09-28 2007-02-01 Gentest Corporation P-glycoproteins and uses thereof
AU3087801A (en) * 2000-02-04 2001-08-14 Molecular Dynamics Inc Human genome-derived single exon nucleic acid probes useful for analysis of geneexpression in human breast and hbl 100 cells
EP1290028B1 (de) 2000-06-05 2009-12-23 The Brigham And Women's Hospital, Inc. Für ein homologes des humanen, für mehrfachresistenz verantwortlichen, p-glykoproteins auf chromosom 7p15-21 kodierendes gen sowie verwendungen dafür
CA2412494C (en) 2000-06-22 2012-10-23 Genentech, Inc. Agonist anti-trk-c monoclonal antibodies
CA2427010A1 (en) * 2000-10-27 2002-05-23 Incyte Genomics, Inc. Transporters and ion channels
US7829336B2 (en) * 2003-11-24 2010-11-09 The Rockefeller University Method for isolating a self-renewing, multipotent, slow-cycling cell
US20050186672A1 (en) 2004-01-27 2005-08-25 Reliance Life Sciences Pvt. Ltd. Tissue system with undifferentiated stem cells derived from corneal limbus
WO2006051405A2 (en) 2004-11-12 2006-05-18 Cambridge University Technical Services Ltd. Methods and means related to cancer stem cells
WO2006103685A2 (en) 2005-03-28 2006-10-05 Vision Research Foundation A method for cultivating cells derived from corneal limbal tissue and cells deived from corneal limbal tissue
AU2006259583A1 (en) 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
HUE059011T2 (hu) * 2006-05-31 2022-09-28 Childrens Medical Center Immunmodulátorként szolgáló ABC5-pozitív mezenchimális õssejtek
CA2698597A1 (en) * 2006-09-07 2008-03-13 Stemline Therapeutics, Inc. Monitoring cancer stem cells
DK2155248T3 (en) 2007-04-12 2015-09-14 Brigham & Womens Hospital Targeting abcb5 for cancer therapy
PT3130923T (pt) 2008-11-14 2020-06-17 Brigham & Womens Hospital Inc Métodos terapêuticos relacionados com células estaminais
AU2014219026B2 (en) 2013-02-19 2018-11-29 Children's Medical Center Corporation ABCB5(+) stem cells for treating ocular disease
EP4008369A1 (de) 2013-05-10 2022-06-08 Children's Medical Center Corporation Wundheilung und gewebeaufbau

Also Published As

Publication number Publication date
EP1290028A2 (de) 2003-03-12
DK2182005T3 (en) 2015-06-29
PT1290028E (pt) 2010-03-12
CY1121053T1 (el) 2019-12-11
US20100145030A1 (en) 2010-06-10
EP2182005A1 (de) 2010-05-05
US20090162873A1 (en) 2009-06-25
EP2182005B1 (de) 2015-03-25
EP1290028B1 (de) 2009-12-23
WO2001094400A2 (en) 2001-12-13
DK2298799T3 (en) 2018-02-19
EP2230253A1 (de) 2010-09-22
US20120034196A1 (en) 2012-02-09
DE60140868D1 (de) 2010-02-04
US8507273B2 (en) 2013-08-13
EP2298799B1 (de) 2017-11-15
EP2230253B1 (de) 2013-08-07
US20020037522A1 (en) 2002-03-28
US6846883B2 (en) 2005-01-25
DK2230253T3 (da) 2013-11-18
CA2411101A1 (en) 2001-12-13
PT2298799T (pt) 2018-02-16
CA2411101C (en) 2018-01-16
US9561264B2 (en) 2017-02-07
HK1257165A1 (en) 2019-10-18
PT2230253E (pt) 2013-11-11
PT2182005E (pt) 2015-07-20
ES2434721T3 (es) 2013-12-17
US7465554B2 (en) 2008-12-16
HK1143823A1 (en) 2011-01-14
EP3333182A1 (de) 2018-06-13
EP2298799A1 (de) 2011-03-23
US8425876B2 (en) 2013-04-23
ES2338756T3 (es) 2010-05-12
US20050049185A1 (en) 2005-03-03
ES2540102T3 (es) 2015-07-08
ES2659877T3 (es) 2018-03-19
US8076091B2 (en) 2011-12-13
CY1109941T1 (el) 2014-09-10
US20130287785A1 (en) 2013-10-31
DK1290028T3 (da) 2010-04-26
WO2001094400A3 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
ATE452909T1 (de) Für ein homologes des humanen, für mehrfachresistenz verantwortlichen, p- glykoproteins auf chromosom 7p15-21 kodierendes gen sowie verwendungen dafür
Zanellati et al. Mitochondrial dysfunction in Parkinson disease: evidence in mutant PARK2 fibroblasts
EP1578371A4 (de) Zusammensetzungen und verfahren für die tumor-diagnose und behandlung
WO2008146309A3 (en) Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
DK1530724T3 (da) Diagnose og forebyggelse af cancercelleinvasion
ATE511653T1 (de) Annexin zur beurteilung des krebsrisikos
Beyer et al. The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies
Guven et al. Peripheral GRN mRNA and serum progranulin levels as a potential indicator for both the presence of splice site mutations and individuals at risk for frontotemporal dementia
EP2264062A4 (de) Beta-faltblatt-inhibierende peptide zur prävention und/oder behandlung von alzheimer-krankheit
ATE470153T1 (de) Diagnostische verfahren für therapeutische verbindungen sowie verfahren zur überwachung der azathioprin-therapie
ATE482976T1 (de) Defensinproteine
WO2008018789A3 (en) Methods and means for diagnosing and treatment of osteoarthritis
Antonell et al. A novel PSEN1 gene mutation (L235R) associated with familial early-onset Alzheimer's disease
Varma et al. Exploring the epigenetic landscape—insights from epigenomics in periodontitis and stress-related health implications: a review
KR101500902B1 (ko) 민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트
WO2009147650A3 (en) Molecular markers for autism
KR101543172B1 (ko) 민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트
CY1114585T1 (el) ΑΝΤΙΣΩΜΑΤΑ ΚΑΤΑ ΕΝΟΣ ΟΜΟΛΟΓΟΥ ΤΗΣ MDR p-ΓΛΥΚΟΠΡΩΤΕΪΝΗΣ ΕΠΑΝΩ ΣΤΟ ΧΡΩΜΟΣΩΜΑ 7p15-21 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
Dimick Neuroimaging as an approach to advancing research on suicide risk among youth with bipolar disorder.
KR101543173B1 (ko) 민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트
KR101543185B1 (ko) 민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트
ATE512983T1 (de) Rezeptor für das tgr3-like protein
DE602004024300D1 (de) Anti-BAMBI Antikörper oder RNA zur Diagnose und Therapie bei Dickdarm- oder Leberkrebs
KR20140130381A (ko) 민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트
e Brito Does Patent Granting Hinder the Development of Gene Therapy Products?

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1290028

Country of ref document: EP